论文部分内容阅读
礼来加拿大公司与加拿大卫生部门联合发布有关阿托莫西汀可使血压升高、心率加快的临床研究报告,最近已将这一新的安全信息加入说明书中。阿托莫西汀为选择性去甲肾上腺素再摄取抑制药,用于治疗儿童和成年人的注意力不集中或多动症。建议如下:①本品禁用于有症状的心血管病患者,中、重度高血压或严重的心血管系统障碍患者,如使用本品可使血压升高或心率加快,导致病情恶化。②本品慎用于具有潜在高血压、心动过速、心血管或脑血管疾病的患者,使用不当,也会使
Eli Lilly and Canadian health authorities jointly issued a clinical study report on the increase of blood pressure and heart rate of atomoxetine. This new safety information has recently been added to the specification. Atomoxetine is a selective norepinephrine reuptake inhibitor used to treat attention deficit hyperactivity disorder (ADHD) in children and adults. The recommendations are as follows: ① This product is forbidden in patients with symptomatic cardiovascular disease, moderate or severe hypertension or severe cardiovascular system disorders, such as the use of this product can make blood pressure or heart rate increased, leading to deterioration. ② This product should be used with caution in patients with potential hypertension, tachycardia, cardiovascular or cerebrovascular diseases, improper use,